Literature DB >> 32436279

Are Cyclin-Dependent Kinase 4/6 Inhibitors Without Future in Neuroendocrine Tumors?

Sara Pusceddu1, Francesca Corti1, Massimo Milione2, Giovanni Centonze2, Natalie Prinzi1, Martina Torchio1, Filippo de Braud1,3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32436279      PMCID： PMC7418349          DOI： 10.1634/theoncologist.2020-0298

Source DB:  PubMed          Journal:  Oncologist        ISSN： 1083-7159


× No keyword cloud information.
  9 in total

1.  Gastroenteropancreatic High-Grade Neuroendocrine Neoplasms: Histology and Molecular Analysis, Two Sides of the Same Coin.

Authors:  Adele Busico; Patrick Maisonneuve; Natalie Prinzi; Sara Pusceddu; Giovanni Centonze; Giovanna Garzone; Alessio Pellegrinelli; Luca Giacomelli; Alessandro Mangogna; Cinzia Paolino; Antonino Belfiore; Ketevani Kankava; Federica Perrone; Elena Tamborini; Giancarlo Pruneri; Nicola Fazio; Massimo Milione
Journal:  Neuroendocrinology       Date:  2019-09-27       Impact factor: 4.914

2.  Inhibition of Rb Phosphorylation Leads to mTORC2-Mediated Activation of Akt.

Authors:  Jinfang Zhang; Kai Xu; Pengda Liu; Yan Geng; Bin Wang; Wenjian Gan; Jianping Guo; Fei Wu; Y Rebecca Chin; Christian Berrios; Evan C Lien; Alex Toker; James A DeCaprio; Piotr Sicinski; Wenyi Wei
Journal:  Mol Cell       Date:  2016-05-26       Impact factor: 17.970

3.  Next-Generation Sequencing of Pulmonary Large Cell Neuroendocrine Carcinoma Reveals Small Cell Carcinoma-like and Non-Small Cell Carcinoma-like Subsets.

Authors:  Natasha Rekhtman; Maria C Pietanza; Matthew D Hellmann; Jarushka Naidoo; Arshi Arora; Helen Won; Darragh F Halpenny; Hangjun Wang; Shaozhou K Tian; Anya M Litvak; Paul K Paik; Alexander E Drilon; Nicholas Socci; John T Poirier; Ronglai Shen; Michael F Berger; Andre L Moreira; William D Travis; Charles M Rudin; Marc Ladanyi
Journal:  Clin Cancer Res       Date:  2016-03-09       Impact factor: 12.531

4.  Somatostatin receptor expression related to TP53 and RB1 alterations in pancreatic and extrapancreatic neuroendocrine neoplasms with a Ki67-index above 20.

Authors:  Björn Konukiewitz; Anna Melissa Schlitter; Moritz Jesinghaus; Dominik Pfister; Katja Steiger; Angela Segler; Abbas Agaimy; Bence Sipos; Giuseppe Zamboni; Wilko Weichert; Irene Esposito; Nicole Pfarr; Günter Klöppel
Journal:  Mod Pathol       Date:  2017-01-06       Impact factor: 7.842

Review 5.  The Strange Case of CDK4/6 Inhibitors: Mechanisms, Resistance, and Combination Strategies.

Authors:  Erik S Knudsen; Agnieszka K Witkiewicz
Journal:  Trends Cancer       Date:  2017-01

Review 6.  New Insights into the Molecular Characteristics of Pulmonary Carcinoids and Large Cell Neuroendocrine Carcinomas, and the Impact on Their Clinical Management.

Authors:  Jules L Derks; Noémie Leblay; Sylvie Lantuejoul; Anne-Marie C Dingemans; Ernst-Jan M Speel; Lynnette Fernandez-Cuesta
Journal:  J Thorac Oncol       Date:  2018-02-14       Impact factor: 15.609

7.  The PALBONET Trial: A Phase II Study of Palbociclib in Metastatic Grade 1 and 2 Pancreatic Neuroendocrine Tumors (GETNE-1407).

Authors:  Enrique Grande; Alex Teulé; Teresa Alonso-Gordoa; Paula Jiménez-Fonseca; Marta Benavent; Jaume Capdevila; Ana Custodio; Ruth Vera; Javier Munarriz; Adelaida La Casta; Juan José Díez; Pablo Gajate; Javier Molina-Cerrillo; Ignacio Matos; Eva María Cristóbal; José C Ruffinelli; José Palacios; Rocío García-Carbonero
Journal:  Oncologist       Date:  2020-02-11

8.  Integrative genomic profiling of large-cell neuroendocrine carcinomas reveals distinct subtypes of high-grade neuroendocrine lung tumors.

Authors:  Julie George; Vonn Walter; Martin Peifer; Ludmil B Alexandrov; Danila Seidel; Frauke Leenders; Lukas Maas; Christian Müller; Ilona Dahmen; Tiffany M Delhomme; Maude Ardin; Noemie Leblay; Graham Byrnes; Ruping Sun; Aurélien De Reynies; Anne McLeer-Florin; Graziella Bosco; Florian Malchers; Roopika Menon; Janine Altmüller; Christian Becker; Peter Nürnberg; Viktor Achter; Ulrich Lang; Peter M Schneider; Magdalena Bogus; Matthew G Soloway; Matthew D Wilkerson; Yupeng Cun; James D McKay; Denis Moro-Sibilot; Christian G Brambilla; Sylvie Lantuejoul; Nicolas Lemaitre; Alex Soltermann; Walter Weder; Verena Tischler; Odd Terje Brustugun; Marius Lund-Iversen; Åslaug Helland; Steinar Solberg; Sascha Ansén; Gavin Wright; Benjamin Solomon; Luca Roz; Ugo Pastorino; Iver Petersen; Joachim H Clement; Jörg Sänger; Jürgen Wolf; Martin Vingron; Thomas Zander; Sven Perner; William D Travis; Stefan A Haas; Magali Olivier; Matthieu Foll; Reinhard Büttner; David Neil Hayes; Elisabeth Brambilla; Lynnette Fernandez-Cuesta; Roman K Thomas
Journal:  Nat Commun       Date:  2018-03-13       Impact factor: 14.919

Review 9.  Are neuroendocrine negative small cell lung cancer and large cell neuroendocrine carcinoma with WT RB1 two faces of the same entity?

Authors:  Dmitriy Sonkin; Anish Thomas; Beverly A Teicher
Journal:  Lung Cancer Manag       Date:  2019-08-21
  9 in total
  1 in total

1.  In Reply.

Authors:  Enrique Grande; Javier Molina-Cerrillo; Teresa Alonso-Gordoa
Journal:  Oncologist       Date:  2020-06-16
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.